The FDA approved Jynneos (Bavarian Nordic) as the first live, nonreplicating vaccine to prevent smallpox and monkeypox.
A recent study suggests that vaccination rates in some Texas schools are low enough to allow for large measles outbreaks, but limiting vaccine exemptions could decrease this risk. Vaccine exemptions, which allow unvaccinated children to attend school, have increased by a factor of 28 since 2003 in Texas.
Our pharmacist team at Osterhaus Pharmacy has been providing immunizations to our patients for the past 2 decades. However, in the past 3 years we have become more proactive in our approach to discussing immunizations.
Life-saving vaccines have had a profound impact in this country and worldwide. According to the CDC, from 2006 to 2017, almost 3.5 billion doses of vaccines were distributed in the United States.
The goal of the Healthy People initiative is to “provide science-based, 10-year national objectives for improving the health of all Americans.”
Ironically, it is often during times when vaccine-preventable disease rates are lowest that public opposition to them is most pervasive, and this certainly seems to be the case with contemporary antivaccination movements in the United States.
Research shows that vaccines prevent disease and save lives. If that is the case, why have specific vaccines been singled out as different from others, creating discord?
The immunization status of pregnant and lactating women should be routinely assessed, and indicated vaccines should be recommended.
An overview of the advancements being made in the practice of immunization coverage and administration.
August is National Immunization Awareness Month and a great time to talk to parents about vaccinations for their children before school.
Troy Trygstad, PharmD, MBA, PhD, leads a discussion on the challenges in vaccine screening and administration, including a consideration of nonflu vaccines, the distribution process, reimbursement issues, and accessibility restrictions.
According to the World Health Organization, 240 vaccines were in development for 25 infectious diseases.5 Topping the list for most candidate vac- cines are HIV/AIDS, malaria, pneumococcal infec- tions, tuberculosis, and Ebola.